Galenica refines its healthcare strategy, shares anchored on SIX Swiss Exchange

By Stefan Krueger, Long-Term & Business Model desk. Reviewed prior to publication on 2026-06-27, 11:07.

Galenica (CH0025536027) sits at the heart of Switzerland’s listed healthcare services sector. The stock trades on the SIX Swiss Exchange, where investors follow the group’s evolution from a traditional pharmacy network into a broader, integrated healthcare platform.

How Galenica positions itself

Galenica presents itself as an integrated healthcare provider, combining pharmacy networks, logistics and healthcare services under one corporate roof, according to its investor relations material. The group highlights a multi-channel presence, with brick-and-mortar pharmacies complemented by digital offerings.

The company segments its activities into areas such as Retail and Services, drawing revenue from prescription drugs, over-the-counter products and distribution logistics. This structure is designed to capture value along the Swiss medicines and healthcare supply chain.

Swiss healthcare and sector peers

On the Swiss equity market, Galenica is often discussed alongside healthcare and life sciences names such as Roche and Novartis, which offer a different, more research-intensive profile. Galenica, by contrast, focuses on distribution, retail and patient-facing services inside Switzerland’s regulated healthcare framework.

Market commentary on Swiss healthcare stocks frequently points to the stability created by mandatory health insurance and regulated reimbursement, which can underpin defensive characteristics in this sector. Galenica’s nationwide pharmacy footprint positions it to benefit from this structural demand.

What the company sells

Galenica’s core business revolves around Swiss pharmacies and pharmaceutical distribution, including prescription medicines, over-the-counter health products and related services. The group also offers value-added healthcare services, such as medication management and support for chronic patients through its pharmacy network.

Where the stock trades today

The Galenica shares (CH0025536027) trade on the SIX Swiss Exchange, where the most recent verifiable quote places the stock at around 80.00 Swiss francs as of 2026-06-26, 16:30.

This text is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities.